The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials

作者：Emma Guttman‐Yassky, David Rosmarin, Marjolein de Bruin‐Weller, Stephan Weidinger, Thomas Bieber, Hwanhee Hong, Hany Elmaraghy, Amber Reck Atwater, Evangeline Pierce, Chenjia Xu, Helena Agell, Esther García Gil, Eric L. Simpson · 发表于：Journal of the American Academy of Dermatology · 年份：2024 · DOI：10.1016/j.jaad.2024.12.026 · 被引用次数：10 · 研究领域：Dermatology and Skin Diseases、Psoriasis: Treatment and Pathogenesis、Allergic Rhinitis and Sensitization